| Literature DB >> 26841328 |
Dapeng Li1, Ming Gao1, Xiaolong Li2, Mingzhao Xing3.
Abstract
Today the most common differentiated thyroid cancer in many countries is papillary thyroid microcarcinoma (PTMC). Although the majority of PTMCs exhibit an indolent clinical course, a few possess high risk for aggressiveness with tumor invasion, metastasis, and even patient mortality. This imposes significant confusion and often dilemma in the clinical management of PTMC. The present review summarizes the molecular pathogenesis, particularly the major genetic alterations, of PTMC that may have prognostic values in assisting risk stratification of this cancer and identification of the most aggressive cases from the many well-behaving cases. J. Cell. Biochem. 117: 1491-1496, 2016.Entities:
Keywords: BRAFV600E; MUTATION; PAPILLARY THYROID MICROCARCINOMA; TERT; miRNA
Mesh:
Year: 2016 PMID: 26841328 DOI: 10.1002/jcb.25506
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429